Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemangioma 9 Melanoma 6 Hemangioma, Capillary 6 Breast Neoplasms 5 Sarcoma 3 Hemangiosarcoma 3 Fallopian Tube Neoplasms 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Hemangioma, Cavernous, Central Nervous System 2 Carcinoma, Ovarian Epithelial 2 von Hippel-Lindau Disease 1 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ulcer 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Sarcoma, Kaposi 1 Recurrent respiratory papillomatosis 1 Recurrence 1 Papilloma 1 Ovarian Neoplasms 1 Neuroblastoma 1

Interventions

Cyclophosphamide 53 Etoposide 33 Temozolomide 28 Irinotecan 28 Melphalan 25 Filgrastim 25 Topotecan 24 Carboplatin 24 3-Iodobenzylguanidine 23 Isotretinoin 20 Granulocyte Colony-Stimulating Factor 17 sargramostim 16 humanized 3F8 anti-GD2 monoclonal antibody 16 dinutuximab 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 fludarabine 15 Vincristine 15 Doxorubicin 15 Cisplatin 15 Peripheral Blood Stem Cell Transplantation 14 Interleukin-2 14 Busulfan 13 naxitamab 12 Thiotepa 12 Radiotherapy 12 aldesleukin 11 fludarabine phosphate 10 etoposide phosphate 8 Mesna 8 Ifosfamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Propranolol × Clear all

NCT02641314 2024-05-10

METRO-NB2012

University of Cologne

Phase 2 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡